专利信息

首页 1 2 3 4 5 6 下页尾页共 62 条记录, 当前第1/7页。

专利标题：Synthetic method for xylometazoline hydrochloride

专利标题：Compositions comprising ipatropium and xylometazoline for treatment of the common cold

专利权人：Nycomed Danmark Aps;

New stable compositions comprising the combination of a topically active vasoconstrictor and a topically active anticholinergic drug are disclosed. Preferably the composition comprises Ipratropium or a salt thereof in combination with Xylometazoline hydrochloride and a salt thereof. Upon topically administering such compositions to a nasal mucosa in individuals suffering from the common cold the symptoms of rhinorrhea are significantly reduced.

专利标题：A kind of compound method of xylometazoline hydrochloride compound

专利标题：Aqueous pharmaceutical solution comprising oxymetazoline and/or xylometazoline

The present invention relates to a stable aqueous solution comprising oxymetazoline and/or xylometazoline a zinc salt and a buffer salt. The aqueous solution is particularly suitable for local administration into the nose for decongesting the mucous membrane.

专利标题：A kind of synthetic method of xylometazoline hydrochloride compound

专利标题：The use of alpha 2 andrenoceptor agonists such as brimonidine for treating inflammatory skin disorders

Disclosed is the use of a compound selected from brimonidine naphazoline oxymetazoline xylometazoline norepinephrine and methoxamine pharmaceutically acceptable salts thereof or combinations thereof for topical administration to treat or prevent an inflammatory skin disorder. More generally disclosed is the use of alpha 2 andrenoceptor agonists to treat inflammatory skin conditions.

专利标题：A kind of compound medicines nasal mist that contains xylometazoline hydrochloride

专利标题：Compounds for enhancing hypoxia inducible factor activity and methods of use

The present invention relates to methods for enhancing Hypoxia inducible factor-1 (HIF) activity in a cell by contacting the cell with any one of the following compounds: 36-bis[2-(dimethylamino)ethoxy]-9h-xanthen-9-onedihydrochloride 28-bis[dimethylaminoacetyl]dibenzofurin dihydrochloride hydrate tilorone analogue R-9536-DA indoprofen ciclopiroxolamine tryptophan ansindione nabumetone oxybendazole albendazole tropicamide pramoxine hydrochloride atenolol mebendazole carbetapentane citrate monens...

专利标题：The aqueous pharmaceutical solution that comprises oxymetazoline and/or xylometazoline

专利标题：Compounds for enhancing hypoxia inducible factor activity and methods of use

The present invention relates to methods for enhancing Hypoxia inducible factor- 1 (HIF) activity in a cell by contacting the cell with any one of the following compounds: 36-bis[2-(dimethylamino)ethoxy]-9h-xanthen-9-onedihydrochloride 28-bis[dimethylaminoacetyl]dibenzofurin dihydrochloride hydrate tilorone analogue R-9536-DA indoprofen ciclopiroxolamine tryptophan ansindione nabumetone oxybendazole albendazole tropicamide pramoxine hydrochloride atenolol mebendazole carbetapentane citrate monen...

当前查询条件: [药品] 包含 'Xylometazoline'

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B

1. CN103351343A	2013/10/16	CN20131293917	2013/7/12
专利标题：Synthetic method for xylometazoline hydrochloride 专利权人：TIANJIN HUAJIN PHARMACEUTICAL CO LTD;

2. EP1661570A3	2012/10/24
专利标题：Compositions comprising ipatropium and xylometazoline for treatment of the common cold 专利权人：Nycomed Danmark Aps; New stable compositions comprising the combination of a topically active vasoconstrictor and a topically active anticholinergic drug are disclosed. Preferably the composition comprises Ipratropium or a salt thereof in combination with Xylometazoline hydrochloride and a salt thereof. Upon topically administering such compositions to a nasal mucosa in individuals suffering from the common cold the symptoms of rhinorrhea are significantly reduced.

3. CN101928247B	2012/5/9
专利标题：A kind of compound method of xylometazoline hydrochloride compound 专利权人：Wuhan Wuyao Technology Co., Ltd.;

4. CA2535533C	2011/10/18	CA20042535533	2004/7/14
专利标题：Aqueous pharmaceutical solution comprising oxymetazoline and/or xylometazoline 专利权人：Merck Patent Gesellschaft Mit Beschraenkter Haftung; The present invention relates to a stable aqueous solution comprising oxymetazoline and/or xylometazoline a zinc salt and a buffer salt. The aqueous solution is particularly suitable for local administration into the nose for decongesting the mucous membrane.

5. CN101928247A	2010/12/29
专利标题：A kind of synthetic method of xylometazoline hydrochloride compound 专利权人：Wuhan Wuyao Technology Co., Ltd.;

6. NZ552325A	2010/11/26	NZ20050552325	2005/5/25
专利标题：The use of alpha 2 andrenoceptor agonists such as brimonidine for treating inflammatory skin disorders 专利权人：Sansrosa Pharmaceutical Development, Inc.; Disclosed is the use of a compound selected from brimonidine naphazoline oxymetazoline xylometazoline norepinephrine and methoxamine pharmaceutically acceptable salts thereof or combinations thereof for topical administration to treat or prevent an inflammatory skin disorder. More generally disclosed is the use of alpha 2 andrenoceptor agonists to treat inflammatory skin conditions.

7. CN101756964A	2010/6/30
专利标题：A kind of compound medicines nasal mist that contains xylometazoline hydrochloride 专利权人：Beijing Lilesheng Pharmaceutical Technology Co., Ltd.;

8. US20090215687A1	2009/8/27	US12/083891	2006/10/20
专利标题：Compounds for enhancing hypoxia inducible factor activity and methods of use 专利权人：Cornell Research Foundation, Inc.; The present invention relates to methods for enhancing Hypoxia inducible factor-1 (HIF) activity in a cell by contacting the cell with any one of the following compounds: 36-bis[2-(dimethylamino)ethoxy]-9h-xanthen-9-onedihydrochloride 28-bis[dimethylaminoacetyl]dibenzofurin dihydrochloride hydrate tilorone analogue R-9536-DA indoprofen ciclopiroxolamine tryptophan ansindione nabumetone oxybendazole albendazole tropicamide pramoxine hydrochloride atenolol mebendazole carbetapentane citrate monens...

9. CN100531733C	2009/8/26	CN20048022793	2004/7/14
专利标题：The aqueous pharmaceutical solution that comprises oxymetazoline and/or xylometazoline 专利权人：Maria Clementine Martin Nun Sales Company;

10. WO2007048004A3	2009/4/30	WO2006US41179	2006/10/20
专利标题：Compounds for enhancing hypoxia inducible factor activity and methods of use 专利权人：Cornell Research Foundation, Inc.; The present invention relates to methods for enhancing Hypoxia inducible factor- 1 (HIF) activity in a cell by contacting the cell with any one of the following compounds: 36-bis[2-(dimethylamino)ethoxy]-9h-xanthen-9-onedihydrochloride 28-bis[dimethylaminoacetyl]dibenzofurin dihydrochloride hydrate tilorone analogue R-9536-DA indoprofen ciclopiroxolamine tryptophan ansindione nabumetone oxybendazole albendazole tropicamide pramoxine hydrochloride atenolol mebendazole carbetapentane citrate monen...

下载范围

下载内容